Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Isaac Eliaz"'
Autor:
Fengyun Wang, Lixin Zhou, Amity Eliaz, Chang Hu, Xinhua Qiang, Li Ke, Glenn Chertow, Isaac Eliaz, Zhiyong Peng
Publikováno v:
Frontiers in Physiology, Vol 14 (2023)
Acute kidney injury (AKI) is a common condition with high morbidity and mortality, and is associated with the development and progression of chronic kidney disease (CKD). The beta-galactoside binding protein galectin-3 (Gal3), with its proinflammator
Externí odkaz:
https://doaj.org/article/c44e01a67bf04765abb3a4b89e301c98
Autor:
Daniel Keizman, Moshe Frenkel, Avivit Peer, Eli Rosenbaum, David Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, Ido Wolf, Ravit Geva, David Margel, Keren Rouvinov, Anat Stern, Hadas Dresler, Igal Kushnir, Isaac Eliaz
Publikováno v:
Nutrients, Vol 15, Iss 16, p 3533 (2023)
The optimal therapy for patients with non-metastatic biochemically relapsed prostate cancer (BRPC-M0) after local therapy is elusive. Thus, the evaluation of new non-toxic compounds in BRPC-M0 patients is warranted. PectaSol®-Modified citrus pectin
Externí odkaz:
https://doaj.org/article/38710bb6eed943709780a09867d92b6b
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-11 (2021)
Abstract Background Galectin-3 (Gal-3) is a pleiotropic glycan-binding protein shown to be involved in sepsis and acute kidney injury (AKI). However, its role has never been elucidated in sepsis-associated AKI (S-AKI). We aimed to explore Gal-3’s r
Externí odkaz:
https://doaj.org/article/6bc540b784984cee937061680cafbb22
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Context: Long-term patient survival in cancer is affected by drug resistance. Honokiol (HNK) is a small-molecule polyphenol isolated from the bark and seed cones of Magnolia officinalis . HNK has been shown to enhance the effects of chemotherapy and
Externí odkaz:
https://doaj.org/article/58bea0495e0d4c94b0da3f95e3a835d3
Autor:
Daniel Keizman, Moshe Frenkel, Avivit Peer, Igal Kushnir, Eli Rosenbaum, David Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, David Margel, Ido Wolf, Ravit Geva, Hadas Dresler, Keren Rouvinov, Noa Rapoport, Isaac Eliaz
Publikováno v:
Nutrients, Vol 13, Iss 12, p 4295 (2021)
Optimal therapy of biochemically relapsed prostate cancer (BRPC) after local treatment is elusive. An established modified citrus pectin (PectaSol®, P-MCP), a dietary polysaccharide, is an established antagonist of galectin-3, a carbohydrate-binding
Externí odkaz:
https://doaj.org/article/e35f3b4284a240c6bc471f263e968b3b
Autor:
Sefora Conti MSc, Akiva Vexler MD, PhD, Lior Hagoel MSc, Lital Kalich-Philosoph PhD, Benjamin W. Corn MD, Nir Honig, Natan Shtraus MSc, Yaron Meir BSc, Ilan Ron MD, PhD, Isaac Eliaz MD, Shahar Lev-Ari PhD
Publikováno v:
Integrative Cancer Therapies, Vol 17 (2018)
Background: Radiotherapy is one of the primary therapies for localized prostatic carcinoma. Therefore, there is an emerging need to sensitize prostatic cancer cells to chemotherapy/radiotherapy. Modified citrus pectin (MCP) is an effective inhibitor
Externí odkaz:
https://doaj.org/article/6b529b2b44f5404c8f466bc8bb08e762
Autor:
Isaac Eliaz, Avraham Raz
Publikováno v:
Nutrients, Vol 11, Iss 11, p 2619 (2019)
Modified citrus pectin (MCP) has a low-molecular-weight degree of esterification to allow absorption from the small intestinal epithelium into the circulation. MCP produces pleiotropic effects, including but not limited to its antagonism of galectin-
Externí odkaz:
https://doaj.org/article/9a0b04fef0394f97a6998c5641bde680
Autor:
Isaac Eliaz
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 2, Pp 343-349 (2013)
In this case study, I report on a patient with stage IV ovarian cancer and underlying pro-inflammatory comorbidities. Initially, the patient's inflammatory condition was treated with an intensive integrative anti-inflammatory protocol using a combina
Externí odkaz:
https://doaj.org/article/f754b8f3282b4088b2f450cc2c6913e3
Autor:
Shujie Cheng, Kristen Swanson, Isaac Eliaz, Jeanette N McClintick, George E Sandusky, Daniel Sliva
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0122270 (2015)
Pachymic acid (PA) is a purified triterpene extracted from medicinal fungus Poria cocos. In this paper, we investigated the anticancer effect of PA on human chemotherapy resistant pancreatic cancer. PA triggered apoptosis in gemcitabine-resistant pan
Externí odkaz:
https://doaj.org/article/b919301d6d704033b3a55938b6461076
Autor:
Daniel Keizman, Moshe A. Frenkel, Avivit Peer, Igal Kushnir, Eli Rosenbaum, David Leonid Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, David Margel, Ido Wolf, Ravit Geva, Keren Rouvinov, Hadas Dresler, Isaac Eliaz
Publikováno v:
Journal of Clinical Oncology. 41:162-162
162 Background: 30% of patients with localized PC will have a biochemical relapse post local therapy. Their optimal treatment remains elusive. While androgen deprivation therapy is effective in reducing PSA level, its long-term benefit remains undefi